Uncovering a tumor suppressor for triple-negative breast cancers

John Albeck, Joan S. Brugge

Research output: Contribution to journal › Review article

15 Citations (Scopus)

Abstract

"Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.

Original languageEnglish (US)
Pages (from-to)638-640
Number of pages3
JournalCell
Volume144
Issue number5
DOIs
StatePublished - Mar 4 2011
Externally publishedYes

Fingerprint

Triple Negative Breast Neoplasms
Protein Tyrosine Phosphatases
Sun
Tumors
Solar System
Neoplasms
Breast Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Uncovering a tumor suppressor for triple-negative breast cancers. / Albeck, John; Brugge, Joan S.

In: Cell, Vol. 144, No. 5, 04.03.2011, p. 638-640.

Research output: Contribution to journal › Review article

Albeck, J & Brugge, JS 2011, 'Uncovering a tumor suppressor for triple-negative breast cancers', Cell, vol. 144, no. 5, pp. 638-640. https://doi.org/10.1016/j.cell.2011.02.030
Albeck J, Brugge JS. Uncovering a tumor suppressor for triple-negative breast cancers. Cell. 2011 Mar 4;144(5):638-640. https://doi.org/10.1016/j.cell.2011.02.030
Albeck, John ; Brugge, Joan S. / Uncovering a tumor suppressor for triple-negative breast cancers. In: Cell. 2011 ; Vol. 144, No. 5. pp. 638-640.
@article{7071d084995c4fb48032bf22dca84335,
title = "Uncovering a tumor suppressor for triple-negative breast cancers",
abstract = "{"}Triple-negative{"} breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.",
author = "John Albeck and Brugge, {Joan S.}",
year = "2011",
month = "3",
day = "4",
doi = "10.1016/j.cell.2011.02.030",
language = "English (US)",
volume = "144",
pages = "638--640",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Uncovering a tumor suppressor for triple-negative breast cancers

AU - Albeck, John

AU - Brugge, Joan S.

PY - 2011/3/4

Y1 - 2011/3/4

N2 - "Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.

AB - "Triple-negative" breast cancers are aggressive malignancies that respond poorly to treatments. Now Sun et al. (2011) find that the activity of the protein tyrosine phosphatase PTPN12 is lost in a large percentage of this breast cancer subtype, offering molecular drivers and possible therapeutic targets for this heterogeneous and intractable cancer.

UR - http://www.scopus.com/inward/record.url?scp=79952306458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952306458&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2011.02.030

DO - 10.1016/j.cell.2011.02.030

M3 - Review article

C2 - 21376226

AN - SCOPUS:79952306458

VL - 144

SP - 638

EP - 640

JO - Cell

JF - Cell

SN - 0092-8674

IS - 5

ER -

Access to Document